id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0133-0003,FDA,FDA-2005-P-0133,FDA/CDER to Mayne Pharma (USA) Inc.,Other,PAV-Petition Approval,2007-01-18T05:00:00Z,2007,1,,,2008-04-12T00:08:30Z,,0,0,090000648043fe17
FDA-2005-P-0133-0001,FDA,FDA-2005-P-0133,HFA-305 to Mayne Pharma (USA) Inc.,Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:08:30Z,,0,0,090000648043fe0e
FDA-2005-P-0133-0002,FDA,FDA-2005-P-0133,HFA-305 to Mayne Pharma (USA) Inc.,Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:08:30Z,,0,0,090000648043fe15